Your browser doesn't support javascript.
loading
yippee like 3 (ypel3) is a novel gene required for myelinating and perineurial glia development.
Blanco-Sánchez, Bernardo; Clément, Aurélie; Stednitz, Sara J; Kyle, Jennifer; Peirce, Judy L; McFadden, Marcie; Wegner, Jeremy; Phillips, Jennifer B; Macnamara, Ellen; Huang, Yan; Adams, David R; Toro, Camilo; Gahl, William A; Malicdan, May Christine V; Tifft, Cynthia J; Zink, Erika M; Bloodsworth, Kent J; Stratton, Kelly G; Koeller, David M; Metz, Thomas O; Washbourne, Philip; Westerfield, Monte.
Afiliación
  • Blanco-Sánchez B; Institute of Neuroscience, University of Oregon, Eugene, Oregon, United States of America.
  • Clément A; Institute of Neuroscience, University of Oregon, Eugene, Oregon, United States of America.
  • Stednitz SJ; Institute of Neuroscience, University of Oregon, Eugene, Oregon, United States of America.
  • Kyle J; Pacific Northwest National Laboratory, Richland, Washington, United States of America.
  • Peirce JL; Institute of Neuroscience, University of Oregon, Eugene, Oregon, United States of America.
  • McFadden M; Institute of Neuroscience, University of Oregon, Eugene, Oregon, United States of America.
  • Wegner J; Institute of Neuroscience, University of Oregon, Eugene, Oregon, United States of America.
  • Phillips JB; Institute of Neuroscience, University of Oregon, Eugene, Oregon, United States of America.
  • Macnamara E; National Institutes of Health Undiagnosed Diseases Program, Common Fund, Office of the Director, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Huang Y; Office of the Clinical Director, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Adams DR; National Institutes of Health Undiagnosed Diseases Program, Common Fund, Office of the Director, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Toro C; National Institutes of Health Undiagnosed Diseases Program, Common Fund, Office of the Director, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Gahl WA; Office of the Clinical Director, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Malicdan MCV; National Institutes of Health Undiagnosed Diseases Program, Common Fund, Office of the Director, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Tifft CJ; Office of the Clinical Director, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Zink EM; National Institutes of Health Undiagnosed Diseases Program, Common Fund, Office of the Director, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Bloodsworth KJ; Section of Human Biochemical Genetics, Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Stratton KG; National Institutes of Health Undiagnosed Diseases Program, Common Fund, Office of the Director, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Koeller DM; National Institutes of Health Undiagnosed Diseases Program, Common Fund, Office of the Director, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Metz TO; Office of the Clinical Director, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Washbourne P; Pacific Northwest National Laboratory, Richland, Washington, United States of America.
  • Westerfield M; Pacific Northwest National Laboratory, Richland, Washington, United States of America.
PLoS Genet ; 16(6): e1008841, 2020 06.
Article en En | MEDLINE | ID: mdl-32544203
ABSTRACT
Hypomyelination, a neurological condition characterized by decreased production of myelin sheets by glial cells, often has no known etiology. Elucidating the genetic causes of hypomyelination provides a better understanding of myelination, as well as means to diagnose, council, and treat patients. Here, we present evidence that YIPPEE LIKE 3 (YPEL3), a gene whose developmental role was previously unknown, is required for central and peripheral glial cell development. We identified a child with a constellation of clinical features including cerebral hypomyelination, abnormal peripheral nerve conduction, hypotonia, areflexia, and hypertrophic peripheral nerves. Exome and genome sequencing revealed a de novo mutation that creates a frameshift in the open reading frame of YPEL3, leading to an early stop codon. We used zebrafish as a model system to validate that YPEL3 mutations are causative of neuropathy. We found that ypel3 is expressed in the zebrafish central and peripheral nervous system. Using CRISPR/Cas9 technology, we created zebrafish mutants carrying a genomic lesion similar to that of the patient. Our analysis revealed that Ypel3 is required for development of oligodendrocyte precursor cells, timely exit of the perineurial glial precursors from the central nervous system (CNS), formation of the perineurium, and Schwann cell maturation. Consistent with these observations, zebrafish ypel3 mutants have metabolomic signatures characteristic of oligodendrocyte and Schwann cell differentiation defects, show decreased levels of Myelin basic protein in the central and peripheral nervous system, and develop defasciculated peripheral nerves. Locomotion defects were observed in adult zebrafish ypel3 mutants. These studies demonstrate that Ypel3 is a novel gene required for perineurial cell development and glial myelination.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Regulación del Desarrollo de la Expresión Génica / Enfermedades Desmielinizantes del Sistema Nervioso Central Hereditarias / Proteínas Supresoras de Tumor / Neurogénesis / Vaina de Mielina Tipo de estudio: Prognostic_studies Límite: Animals / Child / Female / Humans Idioma: En Revista: PLoS Genet Asunto de la revista: GENETICA Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Regulación del Desarrollo de la Expresión Génica / Enfermedades Desmielinizantes del Sistema Nervioso Central Hereditarias / Proteínas Supresoras de Tumor / Neurogénesis / Vaina de Mielina Tipo de estudio: Prognostic_studies Límite: Animals / Child / Female / Humans Idioma: En Revista: PLoS Genet Asunto de la revista: GENETICA Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA